Early tau pathology involving the septo-hippocampal pathway in a tau transgenic model: Relevance to alzheimer's disease

Current Alzheimer Research

Volumn 6, Issue 2, 2009, Pages 152-157

  Belarbi, Karim ^a,b   Schindowski, Katharina ^a,b   Burnouf, Sylvie ^a,b   Caillierez, Raphaëlle ^a,b   Grosjean, Marie Eve ^a,b   Demeyer, Dominique ^a,b   Hamdane, Malika ^a,b   Sergeant, Nicolas ^a,b   Blum, David ^a,b   Buée, Luc ^a,b  

^a INSERM   (France)

^b UNIV LILLE   (France)

Author keywords

Acetylcholine; Axonal transport; Basal forebrain; Neurofibrillary tangles; Phosphorylation

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; FOREBRAIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MEMORY DISORDER; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; STRAIN IDENTIFICATION; SYNAPTIC MEMBRANE; TRANSGENIC MOUSE;

EID: 64549147983     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720509787602843     Document Type: Article

References (31)

1. Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, et al. Proteomics of microtubule-associated Tau in AD and associated neurological disorders. Exp Rev Proteom 5: 207-24 (2008).
2. Sergeant N, Delacourte A and Buée L. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta Mol Biol Dis 1739: 179-97 (2005).
3. Lee VM, Goedert M and Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121-59 (2001).
4. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A and Hof PR. Tau isoforms in neurodegenerative disorders. Brain Res Rev 33:95-130 (2000).
5. Hardy J. A hundred years of Alzheimer's disease research. Neuron 52: 3-13 (2006).
6. Annaert W and De Strooper B. A cell biological perspective on Alzheimer's disease. Annu Rev Cell Dev Biol 18: 25-51 (2002).
7. Davies P and Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403 (1976).
8. Coyle JT, Price DL and DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184-90 (1983).
9. Giacobini E. Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry 18(Suppl 1): S1-5 (2003).
10. Yan Z and Feng J. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid. Curr Alzheimer Res 1: 241-8 (2004).
11. Perez SE, Dar S, Ikonomovic MD, DeKosky ST and Mufson EJ. Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. Neurobiol Dis 28: 3-15 (2007).
12. 1-42 induces neuronal death through the p75 neurotrophin receptor. J Neurosci 28: 3941-6 (2008).
13. Arendt T, Holzer M, Gertz HJ and Brückner MK. Cortical load of PHF-tau in Alzheimer's disease is correlated to cholinergic dysfunction. J Neural Transm 106: 513-23 (1999).
14. Braak H and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-59 (1991).
15. Duyckaerts C, Bennecib M, Grignon Y, Uchihara T, He Y, Piette F, et al. Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 18: 267-73 (1997).
16. Delacourte A, David J-P, Sergeant N, Buée L, Wattez A, Vermersch P, et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52: 115865 (1999).
17. Sassin I, Schultz C, Thal DR, Rub U, Arai K, Braak E, et al. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 100: 259-69 (2000).
18. Mesulam M, Shaw P, Mash D and Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55: 815-28 (2004).
19. Schindowski K, Bretteville A, Leroy K, Bégard S, Brion JP, Hamdane M, et al. Alzheimer disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169(2): 599-616 (2006).
20. Schindowski K, Belarbi K, Bretteville A, Ando K, Begard S, Hamdane M, et al. Neurogenesis and cell cycle reactivation are linked to tau pathology associated neuronal death. Genes Brain Behav 7: 92-100 (2008).
21. Buee-Scherrer V, Condamines O, Mourton-Gilles C, Jakes R, Goedert M, Pau B, et al. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol Brain Res 39: 79-88 (1996).
22. Bussiere T, Hof PR, Mailliot C, Brown CD, Caillet-Boudin ML, Perl DP, et al. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol 97: 221-30 (1999).
23. Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R, et al. Early axonopathy preceding neurofibrillary tangles in a mutant tau transgenic mice. Am J Pathol 171(3): 976-92 (2007).
24. Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 25: 10637-47 (2005).
25. Mufson EJ, Ginsberg SD, Ikonomovic MD and DeKosky ST. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26: 233-42 (2003).
26. Kesner RP. Reevaluation of the contribution of the basal forebrain cholinergic system to memory. Neurobiol Aging 9: 609-16 (1988).
27. Schindowski K, Belarbi K and Buee L. Neurotrophins in Alzheimer disease: role of axonal transport. Genes Brain Behav 7: 43-56 (2008).
28. Dixit R, Ross JL, Goldman YE and Holzbauer EL. Differential regulation of dynein and kinesin motor proteins by tau. Science 319: 1086-9 (2008).
29. Ogawa M, Iida Y, Nakagawa M, Kuge Y, Kawashima H, Tominaga A, et al. Change of central cholinergic receptors following lesions of nucleus basalis magnocellularis in rats: search for an imaging index suitable for the early detection of Alzheimer's disease. Nucl Med Biol 33: 249-54 (2006).
30. Ricceri L, Minghetti L, Moles A, Popoli P, Confaloni A, De Simone R, et al. Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats. Exp Neurol 189: 162-72 (2004).
31. Jhamandas JH, Harris KH, MacTavish D and Jassar BS. Novel excitatory actions of Galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease. J Neurophysiol 87: 696-704 (2002).